Sign In
Buy PCRX
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026
Two Sigma Investments LP Cuts Stock Position in Pacira Biosciences Inc (NASDAQ:PCRX)
08:34am, Monday, 22'nd Jun 2020
Two Sigma Investments LP lessened its position in Pacira Biosciences Inc (NASDAQ:PCRX) by 69.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission.
Pacira Biosciences Inc (NASDAQ:PCRX) Shares Sold by Nuveen Asset Management LLC
05:56am, Saturday, 20'th Jun 2020
Nuveen Asset Management LLC reduced its holdings in Pacira Biosciences Inc (NASDAQ:PCRX) by 18.5% during the first quarter, according to the company in its most recent filing with the SEC. The fund ow
Stifel Nicolaus Remains a Hold on Selecta Biosciences (SELB) - Markets
01:47pm, Thursday, 18'th Jun 2020
Stifel Nicolaus analyst Derek Archila reiterated a Hold rating on Selecta Biosciences (SELB – Research Report) today. The company’s shares
Stifel Nicolaus Keeps Their Hold Rating on Amarin (AMRN) - Markets
10:35pm, Tuesday, 16'th Jun 2020
Stifel Nicolaus analyst Derek Archila reiterated a Hold rating on Amarin (AMRN – Research Report) today. The company’s shares closed
Pacira BioSciences to Present at the 2020 BMO Prescriptions for Success Healthcare Conference
11:30am, Tuesday, 16'th Jun 2020
PARSIPPANY, N.J., June 16, 2020 -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 BMO Prescriptions for Success Healthcare Conference.
Supernus Pharmaceuticals (SUPN) Got Some Good News - Markets
09:34am, Tuesday, 16'th Jun 2020
In a report released today, David Amsellem from Piper Sandler upgraded Supernus Pharmaceuticals (SUPN – Research Report) to Buy, with
Ajo LP Makes New Investment in Pacira Biosciences Inc (NASDAQ:PCRX)
07:39am, Monday, 15'th Jun 2020
Ajo LP bought a new position in Pacira Biosciences Inc (NASDAQ:PCRX) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bo
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC – Research Report),
Jun 10, 2020 (CDN Newswire via Comtex) --
A new offering by MarketandResearch.biz entitled Global Wound Silicone Drainage System Market Growth 2020-2025...
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
08:36pm, Wednesday, 10'th Jun 2020
In this article you are going to find out whether hedge funds think Pacira Biosciences Inc (NASDAQ:PCRX) is a good investment right now. We like to check what the smart money thinks first before doing
The
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
12:00am, Monday, 01'st Jun 2020
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the perspective of drug approvals. Three new molecular...
Lyra Therapeutics: A Chance To Pick Up This ENT Play As It Plateaus Post-IPO (NASDAQ:LYRA)
03:20pm, Friday, 29'th May 2020
Lyra Therapeutics completed its IPO in late-April selling 3.5m shares at a price of $16 - the higher end of expectations - to raise $56m. The company is focused
Pacira BioSciences to Present at the 2020 Jefferies Virtual Healthcare Conference
11:30am, Wednesday, 27'th May 2020
PARSIPPANY, N.J., May 27, 2020 -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 Jefferies Virtual Healthcare Conference at 9:30 AM ET.
